cyclohexanol has been researched along with prednisolone in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (60.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baumann, K; Stiefl, N | 1 |
| Abellán Guillén, A; Cordeiro, MN; Garrido Escudero, A; Morales Helguera, A; Pérez-Garrido, A | 1 |
| Gerlach, C | 1 |
| Buchkremer, G; Laske, C; Leyhe, T; Wormstall, H | 1 |
| Aarya, KR; Grover, S; Sharma, A | 1 |
5 other study(ies) available for cyclohexanol and prednisolone
| Article | Year |
|---|---|
Mapping property distributions of molecular surfaces: algorithm and evaluation of a novel 3D quantitative structure-activity relationship technique.
Topics: Acetates; Alcohols; Algorithms; Cholinergic Agents; Hydrocarbons, Acyclic; Hydrocarbons, Aromatic; Ketones; Models, Molecular; Protein Binding; Quantitative Structure-Activity Relationship; Receptor, Muscarinic M2; Receptors, Muscarinic; Steroids; Transcortin | 2003 |
Convenient QSAR model for predicting the complexation of structurally diverse compounds with beta-cyclodextrins.
Topics: beta-Cyclodextrins; Hydrophobic and Hydrophilic Interactions; Organic Chemicals; Quantitative Structure-Activity Relationship | 2009 |
[Therapeutic experience using the "new" Sural-paste].
Topics: Aluminum; Cyclohexanols; Dermatitis; Dermatitis, Contact; Drug Combinations; Drug Tolerance; Furunculosis; Humans; Ointments; Phenols; Prednisolone; Silicic Acid; Sorbitol; Sulfur; Varicose Ulcer; Zinc | 1974 |
[Depression in Hashimoto's encephalopathy. Successful treatment of a severe depressive episode with a glucocorticoid as an add-on therapy].
Topics: Aged; Chemotherapy, Adjuvant; Cyclohexanols; Depressive Disorder, Major; Drug Combinations; Female; Glucocorticoids; Humans; Prednisolone; Severity of Illness Index; Thyroiditis, Autoimmune; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Use of electroconvulsive therapy in an adolescent with systemic lupus erythematosus for management of depression.
Topics: Adolescent; Alkylating Agents; Anti-Inflammatory Agents; Antidepressive Agents, Second-Generation; Antipsychotic Agents; Benzodiazepines; Bipolar Disorder; Cyclohexanols; Cyclophosphamide; Depressive Disorder, Major; Electroconvulsive Therapy; Female; Humans; Lupus Erythematosus, Systemic; Olanzapine; Prednisolone; Venlafaxine Hydrochloride | 2013 |